Printer Friendly

Printed from http://www.researchandmarkets.com/reports/2096952

In Vitro Diagnostics Market to 2018 - Consolidation, Decentralization and Demand for Genetic Testing to Shape the Competitive Landscape

Description:
“In Vitro Diagnostics Market to 2018 - Consolidation, Decentralization and Demand for Genetic Testing to Shape the Competitive Landscape” provides key data, information and analysis on the global In Vitro Diagnostics (IVD) market. The report provides market landscape, competitive landscape and market trends information on seven IVD market categories: immunochemistry, clinical chemistry, infectious immunology, hematology, microbiology culture, histology and cytology and genetic testing.

The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, with analysis of the major Mergers and Acquisitions (M&A) in the last four years and a detailed analysis of the pipeline products in each category. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.

Scope

- The key geographies include, the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.

- Market size data for seven In Vitro Diagnostics market categories – immunochemistry, clinical chemistry, infectious immunology, hematology, microbiology culture, histology and cytology and genetic testing.

- Annualized market revenue data, seven-year forecasts through to 2018, as well as company share data for 2010.

- Qualitative analysis of key market trends for the In Vitro Diagnostics market.

- Qualitative analysis of market drivers and restraints in each category within the In Vitro Diagnostics market.

- The report also covers information on the leading market players, the competitive landscape, and the leading technologies in the market

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the In Vitro Diagnostics market globally.

- Design and develop your product development, marketing and sales strategies.

- Exploit M&A opportunities by identifying market players with the most innovative pipeline.

- Develop market-entry and market expansion strategies.

- Identify the players best positioned to take advantage of the emerging market opportunities.

- Exploit in-licensing and out-licensing opportunities by identifying products most likely to ensure a robust return.

- What’s the next big thing in the the In Vitro Diagnostics market landscape? – Identify, understand and capitalize.

- Make more informed business decisions from the insightful and in-depth analysis of the global In Vitro Diagnostics market and the factors shaping it.
 
Contents:
1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 Guidance

3 Global In Vitro Diagnostics Market: Market Characterization

3.1 Global in Vitro Diagnostics Market, Revenue ($bn), 2004–2011
3.2 Global In Vitro Diagnostics Market, Revenue ($bn), 2011–2018
3.3 Global In Vitro Diagnostics Market, Key Company Shares (%), 2010
3.4 Global In Vitro Diagnostics Market: Key Market Trends
3.4.1 Growing Trend towards Preventive Healthcare is Driving the Growth of In Vitro Diagnostics
3.4.2 Increased Use of Information Technology in IVD for Effective Workflow Management
3.4.3 Laboratory Consolidation is a Major Trend in the IVD Industry
3.4.4 Demand for Decentralized Laboratory Testing is increasing Significantly Across the World
3.4.5 Consolidation Activity has Increased Significantly in the IVD Industry in Recent Years
3.4.6 Automation is the Key Technology Trend in IVD Market
3.5 Global In Vitro Diagnostics Market: Market Dynamics
3.5.1 Market Drivers
3.5.2 Market Restraints

4 Global In Vitro Diagnostics Market: Market Category Analysis and Forecasts

4.1 In Vitro Diagnostics Market: Cross-Category Analysis
4.2 Immunochemistry
4.2.1 Immunochemistry Market, Global, Revenue ($m), 2004–2011
4.2.2 Immunochemistry Market, Global, Revenue ($m), 2011–2018
4.2.3 Immunochemistry Market, Global, Company Share, (%), 2010
4.3 Immunochemistry Market: Market Dynamics
4.3.1 Market Drivers
4.3.2 Market Restraints
4.4 Clinical Chemistry
4.4.1 Clinical Chemistry Market, Global, Revenue ($m), 2004–2011
4.4.2 Clinical Chemistry Market, Global, Revenue ($m), 2011–2018
4.4.3 Clinical Chemistry Market, Global, Key Company Shares, (%), 2010
4.5 Clinical Chemistry Market: Market Dynamics
4.5.1 Market Drivers
4.5.2 Market Restraints
4.6 Infectious Immunology
4.6.1 Infectious Immunology Market, Global, Revenue ($m), 2004–2011
4.6.2 Infectious Immunology Market, Global, Revenue ($m), 2011–2018
4.6.3 Infectious Immunology Market, Global, Key Company Shares, (%), 2010
4.7 Infectious Immunology Market: Market Dynamics
4.7.1 Market Drivers
4.7.2 Market Restraints
4.8 Hematology
4.8.1 Hematology Market, Global, Revenue ($m), 2004–2011
4.8.2 Hematology Market, Global, Revenue ($m), 2011–2018
4.8.3 Hematology Market, Global, Key Company Shares, (%), 2010
4.9 Hematology Market: Market Dynamics
4.9.1 Market Drivers
4.9.2 Market Restraints
4.10 Microbiology Culture
4.10.1 Microbiology Culture Market, Global, Revenue ($m), 2004–2011
4.10.2 Microbiology Culture Market, Global, Revenue ($m), 2011–2018
4.10.3 Microbiology Culture Market, Global, Company Shares, (%), 2010
4.11 Microbiology Culture Market: Market Dynamics
4.11.1 Market Drivers
4.11.2 Market Restraints
4.12 Histology and Cytology
4.12.1 Histology and Cytology Market, Global, Revenue ($m), 2004–2011
4.12.2 Histology and Cytology Market, Global, Revenue ($m), 2011–2018
4.12.3 Histology and Cytology Market, Global, Company Share, (%), 2010
4.13 Histology and Cytology Market: Market Dynamics
4.13.1 Market Drivers
4.13.2 Market Restraints
4.14 Genetic Testing
4.14.1 Genetic Testing Market, Global, Revenue ($m), 2004–2011
4.14.2 Genetic Testing Market, Global, Revenue ($m), 2011–2018
4.14.3 Genetic Testing Market, Global, Company Share, (%), 2010
4.15 Genetic Testing Market: Market Dynamics
4.15.1 Market Drivers
4.15.2 Market Restraints

5 Global In Vitro Diagnostics Market: Country Analysis and Forecasts

5.1 In Vitro Diagnostics Market: Cross-Country Analysis
5.2 Historic and Forecast Revenue, By Country
5.2.1 In Vitro Diagnostics Market, The US, Revenue ($m), 2004–2011
5.2.2 In Vitro Diagnostics Market, the US, Revenue ($m), 2011–2018
5.2.3 In Vitro Diagnostics Market, Canada, Revenue ($m), 2004–2011.
5.2.4 In Vitro Diagnostics Market, Canada, Revenue ($m), 2011–2018
5.2.5 In Vitro Diagnostics Market, the UK, Revenue ($m), 2004–2011
5.2.6 In Vitro Diagnostics Market, the UK, Revenue ($m), 2011–2018
5.2.7 In Vitro Diagnostics Market, Germany, Revenue ($m), 2004–2011
5.2.8 In Vitro Diagnostics Market, Germany, Revenue ($m), 2011–2018
5.2.9 In Vitro Diagnostics Market, France, Revenue ($m), 2004–2011
5.2.10 In Vitro Diagnostics Market, France, Revenue ($m), 2011–2018
5.2.11 In Vitro Diagnostics Market, Italy, Revenue ($m), 2004–2011
5.2.12 In Vitro Diagnostics Market, Italy, Revenue ($m), 2011–2018
5.2.13 In Vitro Diagnostics Market, Spain, Revenue ($m), 2004–2011
5.2.14 In Vitro Diagnostics Market, Spain, Revenue ($m), 2011–2018
5.2.15 In Vitro Diagnostics Market, Japan, Revenue ($m), 2004–2011
5.2.16 In Vitro Diagnostics Market, Japan, Revenue ($m), 2011–2018
5.2.17 In Vitro Diagnostics Market, China, Revenue ($m), 2004–2011
5.2.18 In Vitro Diagnostics Market, China, Revenue ($m), 2011–2018
5.2.19 In Vitro Diagnostics Market, India, Revenue ($m), 2004–2011
5.2.20 In Vitro Diagnostics Market, India, Revenue ($m), 2011–2018
5.2.21 In Vitro Diagnostics Market, Australia, Revenue ($m), 2004–2011
5.2.22 In Vitro Diagnostics Market, Australia, Revenue ($m), 2011–2018
5.2.23 In Vitro Diagnostics Market, Brazil, Revenue ($m), 2004–2011
5.2.24 In Vitro Diagnostics Market, Brazil, Revenue ($m), 2011–2018

6 Global In Vitro Diagnostics Market: Competitive Assessment

6.1 Key Market Participants
6.1.1 F. Hoffmann–La Roche Ltd.
6.1.2 Siemens Healthcare (Subsidiary of Siemens AG)
6.1.3 Abbott Laboratories
6.1.4 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
6.1.5 Ortho–Clinical Diagnostics Inc. (Subsidiary of Johnson & Johnson)
6.1.6 bioMerieux S.A. (Subsidiary of Merieux Alliance group)
6.1.7 Sysmex Corporation (Sysmex)
6.1.8 Becton, Dickinson and Company
6.1.9 Bio–Rad Laboratories, Inc. (Bio–Rad)
6.1.10 Alere Inc. (formerly Inverness Medical Innovations, Inc.)

7 Global In Vitro Diagnostics Market: Product Pipeline Analysis

7.1 In Vitro Diagnostics Market: Pipeline Products Summary
7.1.1 Pipeline Products Analysis: Immunochemistry Market
7.1.2 Pipeline Products Analysis: Infectious Immunology
7.1.3 Pipeline Products Analysis: Genetic Testing
7.1.4 Pipeline Products Analysis: Clinical Chemistry
7.1.5 Pipeline Products Analysis: Hematology
7.1.6 Pipeline Products Analysis: Microbiology Culture
7.1.7 Pipeline Products Analysis: Histology and Cytology
7.2 In Vitro Diagnostics Market: Profiles of Key Pipeline Products
7.2.1 ImmProCon Technology
7.2.2 RAPIDPoint 500 System – Lactate Assay
7.2.3 Sali – Chek Reader
7.2.4 Point-of-Care Diagnostic Device
7.2.5 ACE Alera Clinical Chemistry System – Direct A1c Assay
7.2.6 Advia 120 Hematology System – IRF Test
7.2.7 Advia 2120 Hematology System – MPC Test
7.2.8 AIA–600 II – D–dimer Test

8 Global In Vitro Diagnostics Market: Consolidation Landscape

8.1 Deals by Number, 2008–2011
8.2 In Vitro Diagnostics Market: Key Deals, 2008–2011
8.2.1 Roche Completes Acquisition of mtm laboratories
8.2.2 bioMerieux Acquires Argene
8.2.3 Thermo Fisher Completes Acquisition of Phadia
8.2.4 Quest Diagnostics Completes Acquisition of Athena Diagnostics
8.2.5 Danaher Completes Acquisition of Beckman Coulter
8.2.6 Laboratory Corporation of America Completes Acquisition of Genzyme Genetics From Genzyme
8.2.7 Merck Completes Acquisition of Millipore
8.2.8 Thermo Fisher Scientific Completes Acquisition of Ahura Scientific
8.2.9 Inverness Medical Innovations Acquires 78.13% Stake in Standard Diagnostics
8.2.10 Quidel Completes Acquisition of Diagnostic HYBRIDS
8.2.11 Danaher Completes Acquisition of Genetix Group
8.2.12 QIAGEN Completes Acquisition of DxS
8.2.13 Thermo Fisher Scientific Completes Acquisition of B.R.A.H.M.S.
8.2.14 Laboratory Corporation of America Holdings Completes Acquisition of Monogram Biosciences
8.2.15 Inverness Medical Innovations Completes Acquisition of Concateno From Marwyn
8.2.16 Gen–Probe Acquires Tepnel Life Sciences
8.2.17 Hologic Acquires Third Wave Technologies
8.2.18 Immucor Acquires BioArray Solutions
8.2.19 Werfen Life Acquires INOVA Diagnostics
8.2.20 Abbott Laboratories Acquires Ibis Biosciences from Isis Pharmaceuticals
8.2.21 bioMerieux Acquires AviaraDx
8.2.22 Bio–Rad Laboratories Acquires Diamed

9 Appendix

9.1 Definitions
9.1.1 Clinical Chemistry
9.1.2 Immunochemistry Test Reagents
9.1.3 Hematology
9.1.4 Histology And Cytology
9.1.5 Microbiology Culture
9.1.6 Infectious Immunology
9.1.7 Genetic Testing
9.2 Sources
9.3 Acronyms
9.4 Research Methodology
9.4.1 Secondary Research
9.4.2 Primary Research
9.4.3 Models
9.4.4 Forecasts
9.4.5 Expert Panels
9.5 Contact Us
9.6 Disclaimer

1.1 List of Tables

Table 1: In Vitro Diagnostics Market, Global, Revenue ($bn), 2004–2011
Table 2: In Vitro Diagnostics Market, Global, Revenue ($bn), 2011–2018
Table 3: Global In Vitro Diagnostics Market, Key Company, Revenue ($m) 2010
Table 4: In Vitro Diagnostics Market, Global, Diagnostics Laboratories, Key M&A Deals, 2007
Table 5: In Vitro Diagnostics Market, Global, Diagnostics Laboratories, Key M&A Deals, 2008–2009
Table 6: Key M&A, IVD Market, Global, 2010–2011
Table 7: In Vitro Diagnostics Market, Global, Cross Category Analysis ,CAGR (%), 2004–2018
Table 8: Immunochemistry Market, Global, Revenue ($m), 2004–2011
Table 9: Immunochemistry Market, Global, Revenue ($m), 2011–2018
Table 10: Global Immunochemistry Market, Key Company, Revenue ($m) 2010
Table 11: Global Immunochemistry Market, Tumor Markers
Table 12: Clinical Chemistry Market, Global, Revenue ($m), 2004–2011
Table 13: Clinical Chemistry Market, Global, Revenue ($m), 2011–2018
Table 14: Clinical Chemistry Market, Global, Key Company Revenue ($m), 2010
Table 15: Infectious Immunology Market, Global, Revenue ($m), 2004–2011
Table 16: Infectious Immunology Market, Global, Revenue ($m), 2011–2018
Table 17: Infectious Immunology Market, Global, Key Company, Revenue ($m) 2010
Table 18: Hematology Market, Global, Revenue ($m), 2004–2011
Table 19: Hematology Market, Global, Revenue ($m), 2011–2018
Table 20: Hematology Market, Global, Key Company Revenue ($m), 2010
Table 21: Microbiology Culture Market, Global, Revenue ($m), 2004–2011
Table 22: Microbiology Culture Market, Global, Revenue ($m), 2011–2018
Table 23: Microbiology Culture Market, Global, Key Company Revenue ($m), 2010
Table 24: Histology and Cytology Market, Global, Revenue ($m), 2004–2011
Table 25: Histology and Cytology Market, Global, Revenue ($m), 2011–2018
Table 26: Histology and Cytology Market, Global, Key Company, Revenue ($m) 2010
Table 27: Genetic Testing Market, Global, Revenue ($m), 2004–2011
Table 28: Genetic Testing Market, Global, Revenue ($m), 2011–2018
Table 29: Genetic Testing Market, Global, Key Company Revenue ($m), 2010
Table 30: In Vitro Diagnostics Market, Global, Genetic Testing, Home Genetic Test Kits, Examples
Table 31: IVD Market, Global, Cross-Country Analysis, CAGR (%), 2004–2018
Table 32: In Vitro Diagnostics Market, The US, Revenue ($m), 2004–2011
Table 33: In Vitro Diagnostics Market, The US, Revenue ($m), 2011–2018
Table 34: In Vitro Diagnostics Market, Canada, Revenue ($m), 2004–2011
Table 35: In Vitro Diagnostics Market, Canada, Revenue ($m), 2011–2018
Table 36: In Vitro Diagnostics Market, The UK, Revenue ($m), 2004–2011
Table 37: In Vitro Diagnostics Market, The UK, Revenue ($m), 2011–2018
Table 38: In Vitro Diagnostics Market, Germany, Revenue ($m), 2004–2011
Table 39: In Vitro Diagnostics Market, the Germany, Revenue ($m), 2011–2018
Table 40: In Vitro Diagnostics Market, France, Revenue ($m), 2004–2011
Table 41: In Vitro Diagnostics Market, France, Revenue ($m), 2011–2018
Table 42: In Vitro Diagnostics Market, Italy, Revenue ($m), 2004–2011
Table 43: In Vitro Diagnostics Market, Italy, Revenue ($m), 2011–2018
Table 44: In Vitro Diagnostics Market, Spain, Revenue ($m), 2004–2011
Table 45: In Vitro Diagnostics Market, Spain, Revenue ($m), 2011–2018
Table 46: In Vitro Diagnostics Market, Japan, Revenue ($m), 2004–2011
Table 47: In Vitro Diagnostics Market, Japan, Revenue ($m), 2011–2018
Table 48: In Vitro Diagnostics Market, China, Revenue ($m), 2004–2011
Table 49: In Vitro Diagnostics Market, China, Revenue ($m), 2011–2018
Table 50: In Vitro Diagnostics Market, India, Revenue ($m), 2004–2011
Table 51: In Vitro Diagnostics Market, India, Revenue ($m), 2011–2018
Table 52: In Vitro Diagnostics Market, Australia, Revenue ($m), 2004–2011
Table 53: In Vitro Diagnostics Market, Australia, Revenue ($m), 2011–2018
Table 54: In Vitro Diagnostics Market, Brazil, Revenue ($m), 2004–2011
Table 55: In Vitro Diagnostics Market, Brazil, Revenue ($m), 2011–2018
Table 56: In Vitro Diagnostics (IVD) Market, Global, Pipeline Products by Category, 2011
Table 57: In Vitro Diagnostics Market, Pipeline Assessment, by Development Stage
Table 58: Immunochemistry Market, Global, Pipeline Products Analysis, 2011
Table 59: Infectious Immunology Market, Global, Pipeline Products Analysis, 2011
Table 60: Genetic Testing Market, Global, Pipeline Products Analysis, 2011
Table 61: Clinical Chemistry Market, Global, Pipeline Products Analysis, 2011
Table 62: Hematology Market, Global, Pipeline Products Analysis, 2011
Table 63: Microbiology Culture Market, Global, Pipeline Products Analysis, 2011
Table 64: Histology and Cytology Market, Global, Pipeline Products Analysis, 2011
Table 65: ImmProCon Technology, Product Status, 2011
Table 66: RAPIDPoint 500 System, Product Status, 2011
Table 67: Sali – Chek Reader, Product Status, 2011
Table 68: Point-of-Care Diagnostic Device, Product Status, 2011
Table 69: ACE Alera Clinical Chemistry System – Direct A1c Assay, Product Status, 2011
Table 70: Advia 120 Hematology System – IRF (Immature Reticulocyte Fraction) Test, Product Status, 2011
Table 71: Advia 2120 Hematology System – MPC (Mean Platelet Component) Test, Product Status, 2011
Table 72: AIA (Automated Immunoassay Analyzer)–600 II – D–dimer Test, Product Status, 2011
Table 73: IVD Market, Mergers and Acquisitions, Number of Deals, Global, 2008–2011
Table 74: In Vitro Diagnostics Market, Global, Mergers and Acquisitions, 2008
Table 75: In Vitro Diagnostics Market, Global, Mergers and Acquisitions, 2009 – Table 1
Table 76: In Vitro Diagnostics Market, Global, Mergers and Acquisitions, 2009 – Table 2
Table 77: In Vitro Diagnostics Market, Global, Mergers and Acquisitions, 2010 – Table 1
Table 78: In Vitro Diagnostics Market, Global, Mergers and Acquisitions, 2010 – Table 2
Table 79: In Vitro Diagnostics Market, Global, Mergers and Acquisitions, 2011 – Table 1
Table 80: In Vitro Diagnostics Market, Global, Mergers and Acquisitions, 2011 – Table 2

1.2 List of Figures

Figure 1: In Vitro Diagnostics Market, Global, Revenue ($bn), 2004–2011
Figure 2: In Vitro Diagnostics Market, Global, Revenue ($bn), 2011–2018
Figure 3: Global In Vitro Diagnostics Market, Key Company Shares (%), 2010
Figure 4: In Vitro Diagnostics Market, Global, Cross-Category Analysis , CAGR (%), 2004–2018
Figure 5: Immunochemistry Market, Global, Revenue ($m), 2004–2011
Figure 6: Immunochemistry Market, Global, Revenue ($m), 2011–2018
Figure 7: Immunochemistry Market, Global, Company Share, (%), 2010
Figure 8: Clinical Chemistry Rapid Tests & POC Market, Global, Revenue ($m), 2004–2011
Figure 9: Clinical Chemistry Market, Global, Revenue ($m), 2011–2018
Figure 10: Clinical Chemistry Market, Global, Key Company, Revenues ($m) 2010
Figure 11: Infectious Immunology Market, Global, Revenue ($m), 2004–2011
Figure 12: Infectious Immunology Market, Global, Revenue ($m), 2011–2018
Figure 13: Infectious Immunology Market, Global, Key Company Shares, (%), 2010
Figure 14: Hematology Market, Global, Revenue ($m), 2004–2011
Figure 15: Hematology Market, Global, Revenue ($m), 2011–2018
Figure 16: Hematology Market, Global, Key Company Shares, (%), 2010
Figure 17: Microbiology Culture Market, Global, Revenue ($m), 2004–2011
Figure 18: Microbiology Culture Market, Global, Revenue ($m), 2011–2018
Figure 19: Microbiology Culture Market, Global, Company Shares, (%), 2010
Figure 20: Histology and Cytology Market, Global, Revenue ($m), 2004–2011
Figure 21: Histology and Cytology Market, Global, Revenue ($m), 2011–2018
Figure 22: Histology and Cytology Market, Global, Company Share, (%), 2010
Figure 23: Genetic Testing Market, Global, Revenue ($m), 2004–2011
Figure 24: Genetic Testing Market, Global, Revenue ($m), 2011–2018
Figure 25: Genetic Testing Market, Global, Company Share, (%), 2010
Figure 26: In Vitro Diagnostics Market, Global, Cross-Country Analysis, CAGR (%), 2004–2018
Figure 27: In Vitro Diagnostics Market, The US, Revenue ($m), 2004–2011
Figure 28: In Vitro Diagnostics Market, the US, Revenue ($m), 2011–2018
Figure 29: In Vitro Diagnostics Market, Canada, Revenue ($m), 2004–2011
Figure 30: In Vitro Diagnostics Market, Canada, Revenue ($m), 2011–2018
Figure 31: In Vitro Diagnostics Market, The UK, Revenue ($m), 2004–2011
Figure 32: In Vitro Diagnostics Market, The UK, Revenue ($m), 2011–2018
Figure 33: In Vitro Diagnostics Market, Germany, Revenue ($m), 2004–2011
Figure 34: In Vitro Diagnostics Market, the Germany, Revenue ($m), 2011–2018
Figure 35: In Vitro Diagnostics Market, France, Revenue ($m), 2004–2011
Figure 36: In Vitro Diagnostics Market, France, Revenue ($m), 2011–2018
Figure 37: In Vitro Diagnostics Market, Italy, Revenue ($m), 2004–2011
Figure 38: In Vitro Diagnostics Market, Italy, Revenue ($m), 2011–2018
Figure 39: In Vitro Diagnostics Market, Spain, Revenue ($m), 2004–2011
Figure 40: In Vitro Diagnostics Market, Spain, Revenue ($m), 2011–2018
Figure 41: In Vitro Diagnostics Market, Japan, Revenue ($m), 2004–2011
Figure 42: In Vitro Diagnostics Market, Japan, Revenue ($m), 2011–2018
Figure 43: In Vitro Diagnostics Market, China, Revenue ($m), 2004–2011
Figure 44: In Vitro Diagnostics Market, China, Revenue ($m), 2011–2018
Figure 45: In Vitro Diagnostics Market, India, Revenue ($m), 2004–2011
Figure 46: In Vitro Diagnostics Market, India, Revenue ($m), 2011–2018
Figure 47: In Vitro Diagnostics Market, Australia, Revenue ($m), 2004–2011
Figure 48: In Vitro Diagnostics Market, Australia, Revenue ($m), 2011–2018
Figure 49: In Vitro Diagnostics Market, Brazil, Revenue ($m), 2004–2011
Figure 50: In Vitro Diagnostics Market, Brazil, Revenue ($m), 2011–2018
Figure 51: In Vitro Diagnostics Market, Global, Competitive Assessment
Figure 52: In Vitro Diagnostics Market, Global, Pipeline Product Summary (%), 2010
Figure 53: In Vitro Diagnostics Market, Pipeline Assessment, by Development Stage
Figure 54: Immunochemistry Market, Global, Pipeline Products Analysis, 2011
Figure 55: Infectious Immunology Market, Global, Pipeline Products Analysis, 2011
Figure 56: Genetic Testing Market, Global, Pipeline Products Analysis, 2011
Figure 57: Clinical Chemistry Market, Global, Pipeline Products Analysis, 2011
Figure 58: Hematology Market, Global, Pipeline Products Analysis, 2011
Figure 59: Microbiology Culture Market, Global, Pipeline Products Analysis, 2011
Figure 60: Histology and Cytology Market, Global, Pipeline Products Analysis, 2011
Figure 61: Cardiovascular Devices Market, Mergers and Acquisitions, Number of Deals, Global, 2008–2011
 
Contents:
In Vitro Diagnostics Market Forecast to Increase at a CAGR of 6.8% during 2011–2018

The global In Vitro Diagnostics (IVD) market is forecast to grow at a Compounded Annual Growth Rate (CAGR) of 6.8% during 2011-2018 to reach a value of $72.3 billion by 2018. The IVD market will be driven by the shift to preventive healthcare from curative healthcare, the increase in the incidence of infectious diseases, the increase in the percentage of elderly people and technological advances.

Technological advances such as automation, biosensor technology, miniaturization, integration of workstations, and Information Technology (IT) optimizing laboratory workflow will lead to an increased demand for innovative technologies and drive the growth of the overall IVD market.

Emerging countries have huge potential for IVD and demand will be high in these countries.

Factors such as an increase in income levels, growing awareness among patients, an increase in the patient pool and the increased adoption of Point of Care (POC) testing will drive the market growth in these countries. The advantages of POC testing include reduced Turnaround Time (TAT), minimal infrastructure requirements and accessibility. These advantages will be major factors contributing to the increased demand for POC tests and will drive the growth of the overall IVD market.

The Immunochemistry Category is expected to be the Largest Revenue Generator

The immunochemistry market is expected to grow at a CAGR of 6.8% during 2011-2018. It will be the largest revenue generator in the IVD market with an expected value of $25.5 billion by 2018. Many factors, such as the increasing incidence of infectious diseases, the fast Turn Around Time (TAT) of these tests and the introduction of innovative tests, will drive the market growth.

Companies are focusing on introducing new tests to meet the growing demand for immunochemistry testing across the world. The immunochemistry market has the highest number of pipeline products in the IVD market. There are a total of 1,726 pipeline products, which accounts for 59% of the total pipeline products in the IVD market.

The increasing prevalence of infectious diseases and cardiac disorders and the increasing elderly population is driving the demand for immunochemistry tests. Physicians are opting for immunochemistry products over other traditional tests due to the short TAT and high specificity of the tests. This has resulted in an increased usage of immunoassays for the diagnosis of various diseases such as infectious diseases, oncology and other disorders. In order to leverage this, the companies are focusing on developing advanced immunochemistry products.
 
Companies Mentioned
- Abbott Laboratories
- Alere Inc. (formerly Inverness Medical Innovations, Inc.)
- Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
- Becton, Dickinson and Company
- bioMerieux S.A. (Subsidiary of Merieux Alliance group)
- Bio–Rad Laboratories, Inc. (Bio–Rad)
- F. Hoffmann–La Roche Ltd.
- Ortho–Clinical Diagnostics Inc. (Subsidiary of Johnson & Johnson)
- Siemens Healthcare (Subsidiary of Siemens AG)
- Sysmex Corporation (Sysmex)
 
Ordering:
Order Online - visit http://www.researchandmarkets.com/reports/2096952

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Page 1 of 2
Printed Apr 25th 2014
4:34:26 AM

Fax order form

To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net

Order information

Please verify that the product information is correct and select the format you require.

Product name

In Vitro Diagnostics Market to 2018 - Consolidation, Decentralization and Demand for Genetic Testing to Shape the Competitive Landscape

Web Address

http://www.researchandmarkets.com/reports/2096952

Office Code

OC8DINOOOOTRUR

 

Report Formats

Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User EUR 2573
Electronic (PDF) - Site License EUR 5146
Electronic (PDF) - Enterprisewide EUR 7718

Contact information

Please enter all the information below in block capitals.

Title:
Mr Mrs Dr Miss Ms Prof
First Name:
Last Name:
Email Address:
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2
Printed Apr 25th 2014
4:34:26 AM

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

American Express

Diners Club

Master Card

Visa

Cardholder's Name:
Cardholder's Signature:
Expiry Date:
/
Card Number:
CVV Security Code:
Issue date:
/ (Diners Club only)
 
Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Pay by Wire Transfer:

Please transfer funds to:

Account Number:
83313083
Sort Code:
98-53-30
Swift Code:
ULSBIE2D
IBAN Number:
IE78ULSB98533083313083
Bank Address:
Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
 

If you have a Marketing Code please enter it below:

Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)